DIABETES AND OBESITY BURDEN AND IMPROVEMENTS IN CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS RECEIVING APREMILAST IN A REAL-WORLD SETTING

Published: 26 February 2024| Version 1 | DOI: 10.17632/zy52nd6c3w.1
Contributors:
Cristi Cavanaugh,
,
,
,
,
,

Description

Mendeley Supplemental Materials for Cristi Cavanaugh et al. DIABETES AND OBESITY BURDEN AND IMPROVEMENTS IN CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH PSORIASIS OR PSORIATIC ARTHRITIS RECEIVING APREMILAST IN A REAL-WORLD SETTING. JAAD International. 2024.

Files

Institutions

Amgen Inc, OM1 Inc

Categories

Diabetes, Obesity, Psoriatic Arthritis, Psoriasis, Body Mass Index

Funding

Amgen

Licence